                </a></li></ul></div><p><strong>Figure 3.  <span>Prognostic value of “stroma up” genes for human prostate cancer.</span></strong></p><a id="article1.body1.sec2.sec4.fig1.caption1.p1" name="article1.body1.sec2.sec4.fig1.caption1.p1"></a><p>(A) Unsupervised hierarchical clustering of prostate cancer patients (columns) obtained using “stroma up” genes (rows).</p>
<a id="article1.body1.sec2.sec4.fig1.caption1.p2" name="article1.body1.sec2.sec4.fig1.caption1.p2"></a><p>Red indicates high relative levels of gene expression and green represents low relative levels of gene expression.</p>
<a id="article1.body1.sec2.sec4.fig1.caption1.p3" name="article1.body1.sec2.sec4.fig1.caption1.p3"></a><p>Genes in the cluster are ordered according to decreasing z values (<a href="#pone.0000032.s007">Table S4</a>).</p>
<a id="article1.body1.sec2.sec4.fig1.caption1.p4" name="article1.body1.sec2.sec4.fig1.caption1.p4"></a><p>“Stroma up” genes divide prostate cancer patients in two main clusters (red and blue); (B) Kaplan-Meier survival analysis of the groups of patients defined by “stroma up” genes shows that the two groups of patients differ significantly in the overall survival time (p = 8.05×10<sup>−5</sup>; red, poor prognosis group; blue, good prognosis group). Similar analyses performed using “stroma down” genes can be found in <a href="#pone.0000032.s003">Figure S3A</a>.</p>
